MAPT and Alzheimer disease: Ex vivo staining of brain homogenates from a tau transgenic mouse and a confirmed AD patient with CyDPA2 supported fluorescence signals corresponding to only tau species and showed a reduction in fluorescent signals with the addition of pyrophosphate (ppi), a phosphate inhibitor.